Literature DB >> 7803271

Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ('Ecstasy').

J C Marsh1, Z H Abboudi, F M Gibson, J Scopes, S Daly, D F O'Shaunnessy, A S Baughan, E C Gordon-Smith.   

Abstract

We report two cases of aplastic anaemia following exposure to 'Ecstasy' (MDMA, 3,4-methylenedioxymethamphetamine). In both cases the aplastic anaemia resolved spontaneously 7-9 weeks after presentation. Long-term bone marrow culture study of one patient demonstrated complete normalization of haemopoiesis at time of haematological recovery, suggesting either that damage to the haemopoietic stem cell had been only transient, or that a more mature, committed progenitor cell was the target. Because MDMA may have been a factor in the aetiology of the bone marrow suppression in these two cases, we recommend close haematological monitoring of young adults presenting with toxicity from MDMA, and a detailed history of exposure to recreational drugs in all new patients presenting with aplastic anaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803271     DOI: 10.1111/j.1365-2141.1994.tb05019.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Ten years of 'ecstasy'.

Authors:  C M Milroy
Journal:  J R Soc Med       Date:  1999-02       Impact factor: 5.344

2.  Pathology of deaths associated with "ecstasy" and "eve" misuse.

Authors:  C M Milroy; J C Clark; A R Forrest
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

Review 3.  Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Authors:  U D McCann; S O Slate; G A Ricaurte
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

4.  Diagnosis and therapeutic decision-making for the neutropenic patient.

Authors:  James A Connelly; Kelly Walkovich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  Bone marrow hypoplasia complicating tacrolimus (FK506) therapy.

Authors:  Annamaria Nosari; Laura Marbello; Luciano G De Carlis; Andrea De Gasperi; Giuliana Muti; Valentina Mancini; Enrica Morra
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

Review 6.  Psychostimulants and movement disorders.

Authors:  Andres Asser; Pille Taba
Journal:  Front Neurol       Date:  2015-04-20       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.